Call Us + 33 1 84 88 31 00

Article L1123-16 of the French Public Health Code

I.- For research, clinical investigations or performance studies involving national defence secrets, the sponsor submits the project for the opinion of a specific committee for the protection of individuals, called the “Defence and National Security Committee for the Protection of Individuals”, approved by the Prime Minister on the proposal of the Minister for Defence and after obtaining the opinion of the Minister for Health. The Prime Minister alone is competent…

Read More »

Article L1123-17 of the French Public Health Code

When the authority designated in article L. 1123-12 or in II of articles L. 1125-1 and L. 1126-1 does not have agents with the level of clearance required for national defence confidentiality, given the level of classification of the research involving the human person, the clinical investigation or the performance study that is envisaged, the competent authority, within the meaning of this article, is the Prime Minister.

Read More »

Article L1123-18 of the French Public Health Code

Any substantial modification at the initiative of the sponsor of a research project, clinical investigation or performance study covered by national defence confidentiality must obtain, prior to its implementation, a favourable opinion from the Defence and National Security Committee for the Protection of Individuals mentioned in I of Article L. 1123-16 and, in the case of research mentioned in 1° of article L. 1121-1, clinical investigations mentioned in II of…

Read More »

Article L1123-19 of the French Public Health Code

For research, clinical investigations or performance studies covered by national defence confidentiality, the sponsor must notify the competent authority of all relevant information relating to the safety of the research, clinical investigation or performance study. Where such research, clinical investigations or performance studies involve persons who have no medical condition and who voluntarily undergo such research, clinical investigations or performance studies, the sponsor shall also notify the Minister for Defence.

Read More »

Article L1123-20 of the French Public Health Code

The procedures for applying this chapter are defined, unless otherwise provided, by decree in the Conseil d’Etat, in particular : 1° The conditions for approval, funding, operation and appointment of the members of the Committee for the Protection of Individuals – Defence and National Security, as well as the nature of the information that must be communicated to it by the sponsor and on which it is required to give…

Read More »

Article L1124-1 of the French Public Health Code

I.- Clinical trials of medicinal products are governed by the provisions of Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014. The competent authority for carrying out the assessment of Part I of the assessment report provided for in Article 6 of this Regulation is the National Agency for the Safety of Medicines and Health Products. The assessment of Part II provided for…

Read More »

Article L1125-1 of the French Public Health Code

I.-The clinical investigations of the devices mentioned in Article 1 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 are governed by the provisions of the aforementioned Regulation (EU) and the provisions of this chapter. II-The competent authority for carrying out the scientific examination as part of the assessment of the clinical investigation request provided for in Article 62(3) and referred to in…

Read More »

Article L1125-2 of the French Public Health Code

Pursuant to Articles 62,70,74,75 and 82 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017, before carrying out a clinical investigation, the sponsor shall submit the project to a personal data protection committee appointed at random from among the committees available and having the necessary competence to examine the project, under the conditions provided for in Article L. 1123-14 or Article L. 1123-16….

Read More »

Article L1125-3 of the French Public Health Code

Once the Data Protection Committee has issued a favourable opinion and the investigation has been authorised by the Agence nationale de sécurité du médicament et des produits de santé, where applicable, any substantial modification at the initiative of the sponsor must obtain a favourable opinion from the Data Protection Committee prior to its implementation and, in the case of clinical investigations referred to in II of Article L. 1125-1, authorisation…

Read More »

Article L1125-4 of the French Public Health Code

In the event of a refusal of validation provided for in paragraph 3 of Article 70 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017, a refusal of authorisation or an unfavourable opinion of a clinical investigation provided for in paragraph 4 of Article 71 of the aforementioned Regulation (EU), the sponsor may submit a request for review to the National Agency for…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.